Homo sapiens Protein: C9 | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Summary | |||||||||||||||||||
InnateDB Protein | IDBP-17896.4 | ||||||||||||||||||
Last Modified | 2014-10-13 [Report errors or provide feedback] | ||||||||||||||||||
Gene Symbol | C9 | ||||||||||||||||||
Protein Name | complement component 9 | ||||||||||||||||||
Synonyms | ARMD15; C9D; | ||||||||||||||||||
Species | Homo sapiens | ||||||||||||||||||
Ensembl Protein | ENSP00000263408 | ||||||||||||||||||
InnateDB Gene | IDBG-17892 (C9) | ||||||||||||||||||
Protein Structure | |||||||||||||||||||
UniProt Annotation | |||||||||||||||||||
Function | Constituent of the membrane attack complex (MAC) that plays a key role in the innate and adaptive immune response by forming pores in the plasma membrane of target cells. C9 is the pore-forming subunit of the MAC. | ||||||||||||||||||
Subcellular Localization | Secreted. Cell membrane; Multi-pass membrane protein. Note=Secreted as soluble monomer. Oligomerizes at target membranes, forming a pre-pore. A conformation change then leads to the formation of a 100 Angstrom diameter pore. | ||||||||||||||||||
Disease Associations | Complement component 9 deficiency (C9D) [MIM:613825]: A rare defect of the complement classical pathway associated with susceptibility to severe recurrent infections predominantly by Neisseria gonorrhoeae or Neisseria meningitidis. Some patients may develop dermatomyositis. {ECO:0000269PubMed:9634479}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.Macular degeneration, age-related, 15 (ARMD15) [MIM:615591]: A form of age-related macular degeneration, a multifactorial eye disease and the most common cause of irreversible vision loss in the developed world. In most patients, the disease is manifest as ophthalmoscopically visible yellowish accumulations of protein and lipid that lie beneath the retinal pigment epithelium and within an elastin-containing structure known as Bruch membrane. {ECO:0000269PubMed:24036952}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. | ||||||||||||||||||
Tissue Specificity | Plasma. | ||||||||||||||||||
Comments | |||||||||||||||||||
Interactions | |||||||||||||||||||
Number of Interactions |
This gene and/or its encoded proteins are associated with 4 experimentally validated interaction(s) in this database.
|
||||||||||||||||||
Gene Ontology | |||||||||||||||||||
Molecular Function |
|
||||||||||||||||||
Biological Process |
|
||||||||||||||||||
Cellular Component |
|
||||||||||||||||||
Protein Structure and Domains | |||||||||||||||||||
PDB ID | |||||||||||||||||||
InterPro |
IPR000884
Thrombospondin, type 1 repeat IPR001862 Membrane attack complex component/perforin/complement C9 IPR002172 Low-density lipoprotein (LDL) receptor class A repeat IPR020864 Membrane attack complex component/perforin (MACPF) domain |
||||||||||||||||||
PFAM |
PF00090
PF00057 PF01823 |
||||||||||||||||||
PRINTS |
PR00764
PR00261 |
||||||||||||||||||
PIRSF | |||||||||||||||||||
SMART |
SM00209
SM00192 SM00457 |
||||||||||||||||||
TIGRFAMs | |||||||||||||||||||
Post-translational Modifications | |||||||||||||||||||
Modification | |||||||||||||||||||
Cross-References | |||||||||||||||||||
SwissProt | P02748 | ||||||||||||||||||
PhosphoSite | PhosphoSite-P02748 | ||||||||||||||||||
TrEMBL | Q9UGI4 | ||||||||||||||||||
UniProt Splice Variant | |||||||||||||||||||
Entrez Gene | 735 | ||||||||||||||||||
UniGene | Hs.654443 | ||||||||||||||||||
RefSeq | NP_001728 | ||||||||||||||||||
HUGO | HGNC:1358 | ||||||||||||||||||
OMIM | 120940 | ||||||||||||||||||
CCDS | CCDS3929 | ||||||||||||||||||
HPRD | 00408 | ||||||||||||||||||
IMGT | |||||||||||||||||||
EMBL | AJ251818 BC020721 J02833 K02766 X02176 Y08545 Y08546 Y08547 Y08548 Y08549 Y08550 Y08551 Y08552 Y08553 Y08554 | ||||||||||||||||||
GenPept | AAA51889 AAA51890 AAH20721 CAA26117 CAA69849 CAB66087 | ||||||||||||||||||